Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
World J Psychiatry. 2024 Jun 19;14(6):760-766. doi: 10.5498/wjp.v14.i6.760. eCollection 2024 Jun 19.
ABSTRACT
The United States is in the throes of a severe opioid overdose epidemic, primarily fueled by the pervasive use of fentanyl and the emerging threat of xylazine, a veterinary sedative often mixed with fentanyl. The high potency and long duration of fentanyl is compounded by the added risks from xylazine, heightening the lethal danger faced by opioid users. Measures such as enhanced surveillance, public awareness campaigns, and the distribution of fentanyl-xylazine test kits, and naloxone have been undertaken to mitigate this crisis. Fentanyl-related overdose deaths persist despite these efforts, partly due to inconsistent policies across states and resistance towards adopting harm reduction strategies. A multifaceted approach is imperative in effectively combating the opioid overdose epidemic. This approach should include expansion of treatment access, broadening the availability of medications for opioid use disorder, implementation of harm reduction strategies, and enaction of legislative reforms and diminishing stigma associated with opioid use disorder.
PMID:38984339 | PMC:PMC11230091 | DOI:10.5498/wjp.v14.i6.760
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
"Coke in the Dope": The Underrecognized Complications of a Cocaine-Adulterated Fentanyl Supply Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl A µ-opioid receptor modulator that works cooperatively with naloxone Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial Fentanyl Test Strips for Harm Reduction: A Scoping Review Fentanyl Test Strips for Harm Reduction: A Scoping Review Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events Transcriptional signatures of fentanyl use in the mouse ventral tegmental area Overdose deaths before and during the COVID-19 pandemic in a US county Assessment of the Antinociceptive, Respiratory-Depressant, and Reinforcing Effects of the Low pKa Fluorinated Fentanyl Analogs, FF3 and NFEPP How Social Workers Can Be Deployed to Assist with the Ongoing Opioid Crisis How Social Workers Can Be Deployed to Assist with the Ongoing Opioid Crisis Combining surface-enhanced Raman spectroscopy (SERS) and paper spray mass spectrometry (PS-MS) for illicit drug detection Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments Naloxone Use During Pregnancy-Data from 26 US Jurisdictions, 2019-2020 Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction) Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction) Inhibition of post-lanosterol biosynthesis by fentanyl: potential implications for Fetal Fentanyl Syndrome (FFS) "Tranq-dope": The first fatal intoxication due to xylazine-adulterated heroin in Italy Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada Opioid Overdose-Induced Diffusion Restriction in the Bilateral Basal Ganglia Revealed on Brain Imaging Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (helping end addiction long-term) communities study At a Crossroads: Opioid Use Disorder, the X-Waiver, and the Road Ahead Maternal deaths by suicide and drug overdose in two Canadian provinces; retrospective review Treating Benzodiazepine Withdrawal in a Bridge Clinic Prescription Opioid Dose Change Prior to Fatal Opioid-Detected Overdose Rapid Response to the Legalization of Fentanyl Test Strips in Alabama: An Academic-Community Partnership Rapid Response to the Legalization of Fentanyl Test Strips in Alabama: An Academic-Community Partnership Implementing Canada's first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS) Adolescent suicide risk factors and the integration of social-emotional skills in school-based prevention programs The Association of Broadband Internet Use With Drug Overdose Mortality Rates in the United States: Cross-Sectional Analysis Impact of the COVID-19 Pandemic on Functions of Nursing Professionals in the Care of Opioid Use Disorder: Systematic Review Prevalence of Opioid Use Disorder and Opioid Overdose Rates Among People With Mental Illness Mindfulness training in medical education as a means to improve resilience, empathy, and mental health in the medical profession Evaluating Sedation Strategies for Magnetic Resonance Imaging: A Comprehensive Review of Intravenous Fentanyl, Butorphanol, and Midazolam in Adult and Pediatric Populations Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation Building bridges to outpatient treatment services for post-overdose care via paramedic buprenorphine field initiation Detecting Substance Use Disorder Using Social Media Data and the Dark Web: Time- and Knowledge-Aware Study Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of de novo lipogenesis and therapeutic consideration "We only trust each other": A qualitative study exploring the overdose risk environment among persons who inject drugs living with HIV in Nairobi, Kenya Clinical and neuroradiographic features of fentanyl inhalation-induced leukoencephalopathy Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder Short-Acting, Full Agonist Opioids During Initiation of Opioid Agonist Treatment in the Fentanyl Era ED50 and ED95 of Remimazolam Tosilate Combined with Different Doses of Fentanyl in Elderly Patients for Painless Gastroscopy Impact of the COVID-19 Pandemic on Youth Substance Use and Substance-Related Risk Factors and Outcomes: Implications for Prevention, Treatment, and Policy Impact of the COVID-19 Pandemic on Youth Substance Use and Substance-Related Risk Factors and Outcomes: Implications for Prevention, Treatment, and Policy Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019-21 Clinical and healthcare use outcomes after cessation of long term opioid treatment due to prescriber workforce exit: quasi-experimental difference-in-differences study Clinical and healthcare use outcomes after cessation of long term opioid treatment due to prescriber workforce exit: quasi-experimental difference-in-differences study Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk Licensure Policies May Help States Ensure Access To Opioid Use Disorder Medication In Specialty Addiction Treatment In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction)
Evidence Blueprint
Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings Xylazine does not enhance fentanyl reinforcement in rats: A behavioral economic analysis Xylazine: A Drug Adulterant of Clinical Concern "Coke in the Dope": The Underrecognized Complications of a Cocaine-Adulterated Fentanyl Supply Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids The fentanyl-specific antibody FenAb024 can shield against carfentanil effects Fentanyl-Type Antagonist of the μ-Opioid Receptor: Important Role of Axial Chirality in the Active Conformation Fentanyl Exposure and Detection Strategies Utilized by Clinical Trial Participants Seeking Linkage to Opioid Use Disorder Treatment at a Syringe Service Program Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review Xylazine and Adulterants in the Evolving Drug Supply: Urgent Call for Responsive Education Models Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont A µ-opioid receptor modulator that works cooperatively with naloxone Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl Cerebellar Leukoencephalopathy following Fentanyl Intoxication. A case report and review of the literature The Fentanyl System Shock - Are There Lessons to Learn From the COVID-19 System Shock Framework? Comment on "The COVID-19 System Shock Framework: Capturing Health System Innovation During the COVID-19 Pandemic" Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial Climate Change and the Opioid Epidemic Fentanyl Test Strips for Harm Reduction: A Scoping Review Fentanyl Test Strips for Harm Reduction: A Scoping Review Old Drugs and New Challenges: A Narrative Review of Nitazenes Implementation and evaluation of interprofessional overdose review team recommendations following intentional or accidental overdose events A Series of 8 Illicit Fentanyl Intoxication Deaths in Infants and Toddlers "Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose A Diagram of the Social-Ecological Conditions of Opioid Misuse and Overdose Transcriptional signatures of fentanyl use in the mouse ventral tegmental area Establishing a research agenda for the study and assessment of opioid withdrawal Systematic review on intentional non-medical fentanyl use among people who use drugs Hippocampal volume loss in individuals with a history of non-fatal opioid overdose Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcement Prevalence and drug use correlates of inadvertent fentanyl exposure among individuals misusing drugs in seven U.S. states Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United States Overdose deaths before and during the COVID-19 pandemic in a US county Assessment of the Antinociceptive, Respiratory-Depressant, and Reinforcing Effects of the Low pKa Fluorinated Fentanyl Analogs, FF3 and NFEPP The Clinical Evolutions of Surveillance and Violence During Three Contemporary US Crises: Opioid Overdose, COVID-19, and Racial Reckoning How Social Workers Can Be Deployed to Assist with the Ongoing Opioid Crisis How Social Workers Can Be Deployed to Assist with the Ongoing Opioid Crisis Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study Combining surface-enhanced Raman spectroscopy (SERS) and paper spray mass spectrometry (PS-MS) for illicit drug detection Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers Initiation of Buprenorphine Treatment of Opioid Use Disorder in Pediatric Emergency Departments Naloxone Use During Pregnancy-Data from 26 US Jurisdictions, 2019-2020 Understanding Regional Patterns of Overdose Deaths Related to Opioids and Psychostimulants Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction) Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction) Inhibition of post-lanosterol biosynthesis by fentanyl: potential implications for Fetal Fentanyl Syndrome (FFS) "Tranq-dope": The first fatal intoxication due to xylazine-adulterated heroin in Italy Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada Youth fatal drug overdose and suicide: Trends in Connecticut, 2019-2021 Opioids in geriatric units in 14 Belgian hospitals: prevalence, dosage and associated factors Opioid Overdose-Induced Diffusion Restriction in the Bilateral Basal Ganglia Revealed on Brain Imaging Prevention and Intervention with Young People as a Critical Public Health Strategy to Curtail the Opioid Epidemic: A Call to Action A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS Feasibility of paying people who use drugs cash to distribute naloxone within their networks Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (helping end addiction long-term) communities study